Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 38,900 Shares of Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 38,900 shares of the stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $35.00, for a total value of $1,361,500.00. Following the sale, the chief executive officer owned 457,935 shares of the company’s stock, valued at $16,027,725. This represents a 7.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.50, for a total value of $643,017.00.
• On Monday, May 11th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $29.12, for a total value of $657,005.44.
• On Friday, April 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $26.72, for a total transaction of $602,856.64.

Heartflow Price Performance

Heartflow stock opened at $35.68 on Friday. The stock has a market cap of $3.08 billion and a P/E ratio of -11.47. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $41.22. The firm’s 50 day moving average price is $30.69 and its 200-day moving average price is $28.60.

Heartflow (NASDAQ:HTFL) last released its earnings results on Thursday, May 14th. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.08. The company had revenue of $52.59 million during the quarter. The company’s quarterly revenue was up 41.3% on a year-over-year basis. As a group, equities analysts expect that Heartflow, Inc. will post -0.82 EPS for the current year.

Institutional Trading of Heartflow

Several hedge funds have recently made changes to their positions in the business. Essential Partners LLC bought a new stake in Heartflow during the first quarter worth approximately $57,000. Bank of America Corp DE lifted its stake in shares of Heartflow by 28.8% in the 1st quarter. Bank of America Corp DE now owns 111,702 shares of the company’s stock valued at $2,718,000 after purchasing an additional 24,964 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in shares of Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after purchasing an additional 1,315,416 shares during the period. California State Teachers Retirement System boosted its holdings in shares of Heartflow by 41.9% in the 1st quarter. California State Teachers Retirement System now owns 29,371 shares of the company’s stock worth $715,000 after purchasing an additional 8,678 shares during the period. Finally, Royal Bank of Canada increased its position in shares of Heartflow by 24.4% during the 1st quarter. Royal Bank of Canada now owns 137,421 shares of the company’s stock valued at $3,343,000 after purchasing an additional 26,912 shares during the last quarter.

Analyst Upgrades and Downgrades

Several research firms have commented on HTFL. Piper Sandler reissued an “overweight” rating on shares of Heartflow in a report on Thursday, June 11th. William Blair assumed coverage on Heartflow in a report on Monday, May 4th. They issued an “outperform” rating on the stock. Weiss Ratings upgraded Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, June 12th. JPMorgan Chase & Co. dropped their price target on Heartflow from $40.00 to $35.00 and set an “overweight” rating for the company in a research note on Thursday, March 19th. Finally, Canaccord Genuity Group cut their price target on Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a report on Friday, May 15th. Six research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $37.00.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.